Results 51 to 60 of about 11,603 (233)

Prognostic Significance of Angiogenic Growth Factor Serum Levels in Patients With Acute Coronary Syndromes [PDF]

open access: yes, 2003
BACKGROUND: In patients with acute coronary syndromes, compensatory processes are initiated, including angiogenesis and endothelial regeneration of ruptured or eroded plaques.
Boersma, H. (Eric)   +5 more
core   +3 more sources

Abciximab: a reappraisal of its use in coronary care

open access: yesBiologics: Targets & Therapy, 2008
Marco Valgimigli, Gianluca Campo, Matteo Tebaldi, Roberto Carletti, Chiara Arcozzi, Roberto Ferrari, Gianfranco PercocoCardiovascular Institute, Azienda Ospedaliera Universitaria S.
Marco Valgimigli   +5 more
doaj  

TEG®6s system measures the contributions of both platelet count and platelet function to clot formation at the site-of-care

open access: yesPlatelets, 2020
Knowledge of platelet count and function is key to ensuring appropriate hemostatic management. We hypothesized that the novel, portable TEG®6s coagulation assessment system could evaluate the contribution of both platelet count and function to clot ...
Joao D. Dias   +5 more
doaj   +1 more source

Self-Reporting Theranostic: Nano Tool for Arterial Thrombosis

open access: yesBioengineering, 2023
Arterial thrombosis (AT) originates through platelet-mediated thrombus formation in the blood vessel and can lead to heart attack, stroke, and peripheral vascular diseases.
Suryyani Deb   +6 more
doaj   +1 more source

Newer agents in antiplatelet therapy: a review. [PDF]

open access: yes, 2012
Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in pathophysiological conditions such as myocardial infarction, ischemia, and stroke.
Holinstat, Michael, Yeung, Jennifer
core   +3 more sources

The FRED‐X Flow Diverter—An Australian Experience

open access: yesJournal of Medical Imaging and Radiation Oncology, Volume 69, Issue 4, Page 484-490, June 2025.
ABSTRACT Background The FRED X flow diverter features antithrombotic surface treatment to reduce thrombogenicity. This study evaluated the safety and efficacy of FRED X in treating intracranial aneurysms in the Australian setting. Methods Clinical, procedural and imaging data were retrospectively reviewed for a consecutive series of patients at a ...
Peter Shuangyue Tan   +6 more
wiley   +1 more source

Trombose de seio dural: relato de caso Dural sinus thrombosis: case report

open access: yesArquivos de Neuro-Psiquiatria, 2006
Relata-se o caso de uma gestante de 24 anos, encaminhada ao serviço de neurologia por apresentar agitação, alucinações, confusão mental, cefaléia, perda de visão, afasia e convulsões.
Asdrubal Falavigna   +2 more
doaj   +1 more source

Hypercoagulability identified in dogs with chronic enteropathy using a point‐of‐care viscoelastic assay

open access: yesJournal of Small Animal Practice, Volume 66, Issue 6, Page 365-371, June 2025.
Objectives Thromboelastography (TEG) using the TEG 6s, a point‐of‐care viscoelastic assay, was prospectively evaluated in dogs with chronic enteropathy (CE). Additionally, the study determined whether disease activity, assessed using the Canine Chronic Enteropathy Clinical Activity Index (CCECAI), correlated with TEG 6s parameters.
S. I. Barth   +3 more
wiley   +1 more source

Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review

open access: yesRevista Portuguesa de Cardiologia, 2019
This article reviews the major pharmacologic features of, and clinical evidence on, adjuvant medical therapy in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.
Daniel Caldeira, Hélder Pereira
doaj   +1 more source

Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes [PDF]

open access: yes, 2003
BACKGROUND: Polymorphonuclear neutrophils (PMNs) have gained attention as critical mediators of acute coronary syndromes (ACS). Myeloperoxidase (MPO), a hemoprotein abundantly expressed by PMNs and secreted during activation, possesses potent ...
Eiserich, J.P. (Jason)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy